Christopher Tobias
Medical · Philadelphia, PANPI 1427453240
Payments from drug & device makers
Across 52 payments — averaging $98.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka Pharmaceutical Development & Commercialization, Inc.$1K
- Novo Nordisk$638
- GSK$497
- AstraZeneca$377
- Gilead$375
- AbbVie$243
- plus $2K from 17 others
What the payments were for
- Consulting fees$1,05020%
- Food & beverage$4,07280%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 3 | $1,155 |
| Novo Nordisk | 10 | $638 |
| GSK | 7 | $497 |
| AstraZeneca | 3 | $377 |
| Gilead | 5 | $375 |
| AbbVie | 2 | $243 |
| Amgen | 2 | $240 |
| Biohaven Pharmaceuticals, Inc. | 3 | $178 |
| Inari Medical, Inc. | 1 | $160 |
| Teva Pharmaceuticals USA, Inc. | 1 | $132 |
| Astellas Pharma US Inc | 1 | $125 |
| Sumitomo Pharma America, Inc. | 1 | $124 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $123 |
| E.r. Squibb & Sons, L.L.C. | 1 | $122 |
| Inspire Medical Systems, Inc. | 1 | $120 |
| Coloplast | 1 | $114 |
| Neurocrine Biosciences, Inc. | 1 | $113 |
| Sanofi Pasteur Inc. | 1 | $98 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $94 |
| Therapeuticsmd, Inc. | 2 | $32 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $28 |
| Lilly USA, LLC | 1 | $18 |
| Merck | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ULTOMIRIS$257
- TRELEGY ELLIPTA$240
- Ozempic$234
- RYBELSUS$230
- NUCALA$227
- FLOWTRIEVER CATHETER, S$160
- CT THROMBECTOMY SYSTEM KIT$160
- AUSTEDO$132
- ORIAHNN$126
- Veozah$125
- NURTEC ODT$125
- MYFEMBREE$124
- Yeztugo$123
- Descovy$123
- ZEPOSIA$122
- AIMOVIG$120
- Repatha$120
- Inspire$120
- QULIPTA$116
- TITAN$114
How this compares
$5,122 in reported general payments places this provider in the 90th percentile of 2,594 medical providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tolterodine Tartrate | 12 | $243 |
Paid to pharmacies, not to this prescriber.
Other medical in Philadelphia
- Angela KapalkoPhiladelphia$123K
- Linda PerryPhiladelphia$123K
- Sarah SmithPhiladelphia$65K
- Victoria WongPhiladelphia$51K
- Parth PatelPhiladelphia$46K
- Zachary LutzPhiladelphia$30K
- Hawah MusaPhiladelphia$13K
- Carl BlackPhiladelphia$13K
- Ashley BarratPhiladelphia$12K
- Jacqueline KernaghanSpringfield$427K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.